Tradestie Institutional Equity Comparison Engine
TSHA vs MPLT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TSHA Overall Edge
TSHA Captures Institutional Edge (3โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Taysha Gene Therapies, Inc. Common Stock (TSHA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TSHA trades at N/M Forward P/E with -2998.0% operating margin (+171.3% YoY revenue) versus MPLT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, TSHA sits in BREAKDOWN (34th %ile IV; Dealer Gamma Walls on Pro) against MPLT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
TSHA N/M vs MPLT N/M Fwd P/E
Growth & Margin Winner
TSHA
Op Margin -2998.0% vs 0.0% ยท YoY +171.3% vs +0.0%
Momentum & Technical Winner
TSHA
1Y -7.2% vs -59.3% ยท 52W Pos 7% vs 0%
Options & Structure Winner
TSHA
BREAKDOWN (34th %ile IV) vs BREAKDOWN (9th %ile IV)
TSHA
NASDAQ
Taysha Gene Therapies, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$3.72
-1.33% 1D
Market Cap
$1.2B
1M Return
-7.12%
1Y Return
-7.23%
Forward P/E
N/M
Unified AI Score
49.8 / 100
HOLD
Tech 25.0
Fund 51.0
Flow 69.0
Mom 64.0
MPLT
US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$5.94
-7.48% 1D
Market Cap
$356.8M
1M Return
-28.0%
1Y Return
-59.32%
Forward P/E
N/M
Unified AI Score
48.3 / 100
HOLD
Tech 33.0
Fund 64.0
Flow 67.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TSHA -7.23%
MPLT -59.32%
Spread: +52.09 pp (TSHA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
TSHA TTM Op. Margin: -2998.0%
MPLT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TSHA vs MPLT. Trailing 12-month operating profitability (TSHA -2998.0% vs MPLT 0.0%) and valuation multiples (TSHA N/M vs MPLT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TSHA | MPLT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $356.8M | Larger Scale | TSHA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +171.3% | +0.0% | Higher Growth | TSHA |
| Operating Margin (TTM) Profitability | -2998.0% | 0.0% | Higher Margin | MPLT |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -54.2% | -74.2% | Higher ROE | TSHA |
| 52-Week Range Position Momentum | 7% ($3โ$7) | 0% ($6โ$40) | Stronger Trend | TSHA |
| Beta / 30D Volatility Risk Regime | 1.81ฮฒ ยท 52% Vol | 1.19ฮฒ ยท 79% Vol | Lower Realized Risk | TSHA |
| Unified Institutional Score Composite Signal | 49.8 / 100 (HOLD) | 48.3 / 100 (HOLD) | Higher Composite | TSHA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TSHA vs MPLT Buy Guide
TSHA
BREAKDOWN
138d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
34th %ile
IV Regime
Balanced (25thโ60th %ile)
MPLT
BREAKDOWN
148d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TSHA nor MPLT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.